ROZ logo

Roche Holding BATS-CHIXE:ROZ Stock Report

Last Price

CHF 261.20

Market Cap

CHF 198.6b

7D

-3.4%

1Y

0.5%

Updated

23 Dec, 2024

Data

Company Financials +

Roche Holding AG

BATS-CHIXE:ROZ Stock Report

Market Cap: CHF 198.6b

ROZ Stock Overview

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. More details

ROZ fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health3/6
Dividends5/6

My Notes

Capture your thoughts, links and company narrative

Roche Holding AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Roche Holding
Historical stock prices
Current Share PriceCHF 261.20
52 Week HighCHF 311.80
52 Week LowCHF 229.80
Beta0.14
1 Month Change-2.90%
3 Month Change-8.96%
1 Year Change0.54%
3 Year Change-36.54%
5 Year Changen/a
Change since IPO40.54%

Recent News & Updates

Recent updates

Shareholder Returns

ROZGB PharmaceuticalsGB Market
7D-3.4%-2.0%-2.2%
1Y0.5%-3.5%2.4%

Return vs Industry: ROZ exceeded the UK Pharmaceuticals industry which returned -3.5% over the past year.

Return vs Market: ROZ underperformed the UK Market which returned 2.4% over the past year.

Price Volatility

Is ROZ's price volatile compared to industry and market?
ROZ volatility
ROZ Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: ROZ has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: ROZ's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1896103,605Thomas Schineckerwww.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas.

Roche Holding AG Fundamentals Summary

How do Roche Holding's earnings and revenue compare to its market cap?
ROZ fundamental statistics
Market capCHF 198.60b
Earnings (TTM)CHF 10.62b
Revenue (TTM)CHF 60.58b

18.6x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ROZ income statement (TTM)
RevenueCHF 60.58b
Cost of RevenueCHF 15.43b
Gross ProfitCHF 45.16b
Other ExpensesCHF 34.54b
EarningsCHF 10.62b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)13.33
Gross Margin74.54%
Net Profit Margin17.53%
Debt/Equity Ratio104.8%

How did ROZ perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

72%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:18
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Roche Holding AG is covered by 59 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
John StaszakArgus Research Company
Gerhard SchwarzBaader Helvea Equity Research